ISRG Preview Mode — Vezi un preview — analiza completa cu Strategy Signals, Smart Money 13F si Insider Trades disponibila cu cont. Sign Up Free → sau Login
📡 SignalRadar — RadarScope
Intuitive Surgical, Inc.
ISRG NASDAQ Healthcare Medical - Instruments & Supplies
$372.6
1M: +5.5% | 3M: -9.6%
Calitate
Q10
Risc
R6
Scor AI
0
Verdict
TINE
Market Cap
$131.6B
P/E Ratio
42.1
Profit Margin
28.4%
ROE
17.8%
📈 Earnings Report — 2026-07
Ultimul trimestru raportat
EPS Actual
$2.8
▲ 0.0% QoQ▲ 27.9% YoY
EPS Estimat
$2.48
Beat by 12.9%
Revenue Actual
$2.89B
▲ 4.4% QoQ▲ 18.5% YoY
Revenue Estimat
$2.83B
Beat by 2.4%
Istoric Ultimele 4 Trimestre
2026-07
EPS Actual
$2.8
EPS Est.
$2.48
Revenue
$2.89B
Beat/Miss
Beat by 12.9%
2026-04
EPS Actual
$2.8
EPS Est.
$2.51
Revenue
$2.77B
Beat/Miss
Beat by 11.6%
2026-01
EPS Actual
$2.53
EPS Est.
$2.27
Revenue
$2.87B
Beat/Miss
Beat by 11.5%
2025-10
EPS Actual
$2.4
EPS Est.
$1.99
Revenue
$2.51B
Beat/Miss
Beat by 20.6%
Urmatorul Raport
Data
2026-10-20
EPS Estimat
$2.61
Revenue Estimat
$2.91B
📊 Scoruri Companie
Crestere 9/10
9
Revenue & Profit Growth
Evaluare 2/10
2
P/E · P/B · P/S
Calitate 10/10
10
Marje · ROE · Datorii
Risc 6/10
6
Beta · Market Cap
📈 Date Financiare Istorice in miliarde USD
💰 Revenue
📊 Net Profit
💵 Cash Flow
Operating (albastru) · Free (violet)
🏦 Cash & Datorii
Cash (verde) · Long-term Debt (rosu)
💸 Operating Expenses
🤖 Analiza RadarScope AI
Analiza AI (verdict, bull case, bear case) este disponibila pe planurile Trader si Elite.
💡 Disponibil pe Trader / Elite
🐂 BULL CASE
Disponibil pe Trader / Elite
🐻 BEAR CASE
Disponibil pe Trader / Elite
TINE Upgrade la Trader sau Elite pentru verdictul AI.
📖 Indicatorii lui Lynch — concluzii rapide dupa Peter Lynch
PEG — P/E in contextul cresterii
CAM SCUMP
PEG 1.93 · cu dividend 1.93 · crestere EPS ~21.8%/an. Regula Lynch: ~1 corect, sub 0.5 foarte atractiv, peste 2 scump.
P/E vs istoria proprie si sectorul
P/E acum 42.1.
vs media proprie 5 ani (72.6): SUB media sa
vs sector Healthcare (22.2): PESTE sector
Lynch: compara P/E cu propria istorie si media industriei, nu in absolut.
Procentul din vanzari (concentrare produs)
MODERAT CONCENTRAT
Instruments and Access 60% · Systems 25% · Services 16%
Lynch: un produs genial care aduce sub ~10% din venituri nu misca actiunea.
Cash si datorie
CASH NET POZITIV
Cash net pe actiune $16.32 (~4% din pret e deja acoperit de bani lichizi).
Tip datorie: OK — TERMEN LUNG — majoritar pe termen lung (obligatiuni = timp de manevra). Scurt $39.0M / Lung $131.9M.
Marje de profit
MARJE SOLIDE
Bruta 66.7% · Operationala 31.3% · Neta 28.4%. Marje mari — de regula castigatorul pe termen lung din industrie.
Inventare vs vanzari
OK
Stocurile NU cresc mai repede ca vanzarile (inventar +24% vs vanzari +21%).
Povestea in 2 minute
De ce o detii: Analiza AI (verdict, bull case, bear case) este disponibila pe planurile Trader si Elite.
Ce trebuie sa mearga bine: Disponibil pe Trader / Elite
Obstacole: Disponibil pe Trader / Elite
Lynch: daca nu poti explica coerent in 2 minute de ce o detii, nu o intelegi.
🔬 Analiza Fundamentala Avansata · an fiscal 2025-12-31
🏦 Altman Z-Score
33.73 ZONA SIGURA
X1 Capital de lucru / Active0.38x1.2
X2 Profit reportat / Active0.343x1.4
X3 EBIT / Active0.144x3.3
X4 Capitalizare / Datorii53.037x0.6
X5 Vanzari / Active0.492x1.0
Praguri Altman (1968): >2,99 sigur · 1,81–2,99 gri · <1,81 pericol de faliment
💪 Piotroski F-Score
8/9 PUTERNIC
ROA pozitiv13.96%
Cash flow operational pozitiv3.03B
ROA in crestere13.96% vs 12.39%
Cash flow > Profit net (calitate)3.03B vs 2.86B
Datorie pe termen lung in scadere0.0% vs 0.0% din active
Lichiditate curenta in crestere4.87 vs 4.07
Fara emisiune de actiuni noi355.1M vs 356.6M
Marja bruta in crestere66.0% vs 67.5%
Rotatia activelor in crestere0.49 vs 0.45
9 teste binare (Piotroski, 2000). 8–9 = putere financiara · 0–2 = slabiciune
⚖️ ROIC vs WACC
+5.47pp CREEAZA VALOARE
ROIC (randamentul capitalului)17.70%
WACC (costul capitalului)12.23%
Ipoteze (la vedere):
Rata fara risc 4.2% (USD) · Beta 1.46 · Prima de risc 5.5%
Cost capitaluri proprii 12.23% · Cost datorie 0.0% · Impozit efectiv 13.1%
Metode publice: Altman, E. (1968), Journal of Finance · Piotroski, J. (2000), Journal of Accounting Research · ROIC/WACC prin CAPM. Fiecare cifra isi arata componentele si pragurile — poti reface calculul manual.
📊 Metrici Fundamentale
P/E TTM42.1
P/B TTM7.27
P/S TTM11.93
EV/EBITDA28.6
Gross Margin66.7%
Operating Margin31.3%
Net Margin28.4%
ROE17.8%
ROA15.0%
Debt/Equity
Current Ratio4.96
FCF Yield2.4%
Dividend Yield
Beta1.46
💰 Venituri & Profit (ultimele trimestre)
TrimestruRevenueGross ProfitNet IncomeEPS
2026-06$2.9B$2.0B$818.1M$2.32
2026-03$2.8B$1.8B$821.5M$2.31
2025-12$2.9B$1.9B$794.8M$2.24
2025-09$2.5B$1.7B$704.4M$1.98
🏢 Profil Companie
CEODavid J. Rosa
Angajati17021
IPO2000-06-16
52W High$603.88
52W Low$328.57
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyon...
🎯 Score Breakdown
Calitate Companie (Q) 10/10
Risc Speculativ (R) 6/10
Scor AI RadarScope 0/100
VERDICT FINAL
TINE
Upgrade la Trader sau Elite pentru verdictul AI.
🤖 Chat AI — Intreaba despre ISRG
RadarScope AI
Buna! Pot raspunde la orice intrebare despre ISRG. Ce vrei sa stii?

🔒 Analiza completa disponibila cu cont SignalRadar

Vezi Strategy Signals AI (Triple Oversold, BB Squeeze), Smart Money 13F ($837 mld Berkshire+BlackRock+Vanguard), Insider Trades live SEC Form 4, News + Short Interest in timp real, 20+ indicatori tehnici Multi-TF.

🚀 Cont Gratuit (25 tickere) Vezi planurile platite (de la $4.99)
+ 13F Smart Money+ Form 4 Insider+ TA MEGA 20+ indicatori+ AI Signals Triple Oversold etc.+ Multi-TF 1D/1W/1M
[!] Datele sunt informative. NU constituie sfat investitional personalizat. Decizia de investitie iti apartine. Detalii